Discover life-changing eczema treatments and remedies that provide real relief. From prescription breakthroughs to natural ...

Incyte (Nasdaq: INCY) today announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the ...

The FDA pushed back the Prescription Drug User Fee Act action date for ruxolitinib cream (Opzelura) by three months to September 19, 2025. The extension will allow regulators time to review additional ...

I’ve had to learn that just because I don’t have eczema myself, it doesn’t mean I can remain ignorant about it and the effect it has on my kids. Not if I want to help them.

An irritating skin condition is flaring up for a third of Australians trying to keep warm this winter, made worse by heaters, ...

Explore the link between eczema children and genetics. Learn how household dogs may help reduce skin irritation risks.

Ruxolitinib 0.75% cream and ruxolitinib 1.5% cream are effective and well-tolerated in children aged 2 to 11 years with atopic dermatitis.

Research indicates that early exposure to dogs may mitigate genetic risks associated with eczema in children. A specific gene ...

Our panel of 110 parents tested 11 nappy creams to see which were the gentlest on their little one's bottoms. Shop the ...

Medically reviewed by Katlein Franca, MD Eczema is a chronic (long-lasting) inflammatory condition that causes rashes of scaly, irritated, itchy, dry skin. Affected areas can change color and harden.

Arcutis Biotherapeutics has enrolled the first child in an open-label Phase II trial of Zoryve (roflumilast) for atopic dermatitis.